Whitehawk Therapeutics (WHWK) Assets Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Whitehawk Therapeutics | 312.26 Mn | 189.22 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25.32% |
| Dec 31, 2025 | 51.62% |
| Sep 30, 2025 | 27.37% |
| Jun 30, 2025 | 31.65% |
| Mar 31, 2025 | 45.65% |
| Dec 31, 2024 | 11.98% |
| Sep 30, 2024 | 13.47% |
| Jun 30, 2024 | 15.42% |
| Mar 31, 2024 | 15.07% |
| Dec 31, 2023 | 15.61% |
| Sep 30, 2023 | 14.76% |
| Jun 30, 2023 | 16.81% |
| Mar 31, 2023 | 63.21% |
| Dec 31, 2022 | 54.35% |
| Sep 30, 2022 | 49.49% |
| Jun 30, 2022 | 33.98% |
| Mar 31, 2022 | 31.44% |
| Dec 31, 2021 | 131.07% |
| Sep 30, 2021 | 635.58% |
| Jun 30, 2021 | 350.01% |
| Mar 31, 2021 | 399.57% |
| Dec 31, 2020 | 299.37% |
| Sep 30, 2020 | 502.62% |
| Jun 30, 2020 | 438.51% |
| Mar 31, 2020 | 333.62% |
| Dec 31, 2019 | 497.07% |
| Sep 30, 2019 | 380.05% |
| Jun 30, 2019 | 541.43% |
| Mar 31, 2019 | 510.20% |
| Dec 31, 2018 | 492.48% |
| Sep 30, 2018 | 444.42% |
| Jun 30, 2018 | 419.26% |
| Mar 31, 2018 | 421.20% |
| Dec 31, 2017 | 381.71% |
| Sep 30, 2017 | 370.59% |
| Jun 30, 2017 | 353.34% |
| Mar 31, 2017 | 331.61% |
| Dec 31, 2016 | 224.86% |
| Sep 30, 2016 | -5.69% |
| Jun 30, 2016 | 5.55% |
| Dec 31, 2015 | -8.82% |